loratadine has been researched along with promethazine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cuss, FM; Del Prado, M; Egan, RW; Hey, JA; Kreutner, W; Lin, CC; Sherwood, J | 1 |
| Fairweather, DB; Hindmarch, I; Shamsi, Z; Stanley, N | 1 |
| Hindmarch, I; Kimber, S; Shamsi, Z | 1 |
| Hindmarch, I; Johnson, S; Kirkpatrick, T; Meadows, R; Shamsi, Z | 1 |
| Baldauf, S | 1 |
| Anoopkumar-Dukie, S; Grant, GD; Kavanagh, JJ | 1 |
| Yanai, K | 1 |
| Callaghan, JT; Duke, JD; Flockhart, DA; Hall, SD; Han, X; Jin, Y; Karnik, SD; Li, L; Li, X; Overhage, MJ; Quinney, SK; Strother, RM; Subhadarshini, A; Wang, Z | 1 |
| Anoopkumar-Dukie, S; Grant, GD; Kavanagh, JJ; Naicker, P | 1 |
| Anoopkumar-Dukie, S; Baumann-Birkbeck, L; Grant, GD; Kavanagh, JJ | 1 |
1 review(s) available for loratadine and promethazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for loratadine and promethazine
| Article | Year |
|---|---|
A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function.
Topics: Adult; Cognition; Cross-Over Studies; Double-Blind Method; Female; Flicker Fusion; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Loratadine; Male; Middle Aged; Promethazine; Psychomotor Performance; Reaction Time; Terfenadine; Wrist | 1999 |
An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers.
Topics: Adult; Cetirizine; Cognition; Cross-Over Studies; Double-Blind Method; Female; Flicker Fusion; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Promethazine; Psychomotor Performance; Reaction Time | 2001 |
The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare.
Topics: Adult; Analysis of Variance; Area Under Curve; Cetirizine; Cognition; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Promethazine; Psychometrics; Psychomotor Performance; Reaction Time; Skin Tests | 2001 |
Low dosage promethazine and loratadine negatively affect neuromotor function.
Topics: Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Motor Neurons; Movement; Promethazine; Reaction Time; Sleep Stages; Tremor; Young Adult | 2012 |
The effects of antihistamines with varying anticholinergic properties on voluntary and involuntary movement.
Topics: Adult; Cholinergic Antagonists; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Promethazine; Reaction Time; Sleep Stages; Terfenadine; Tremor; Young Adult | 2013 |
Drowsiness and motor responses to consecutive daily doses of promethazine and loratadine.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Promethazine; Reaction Time; Sleep Stages; Tremor; Young Adult | 2014 |
10 other study(ies) available for loratadine and promethazine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.
Topics: Animals; Cardiovascular System; Central Nervous System; Diphenhydramine; Electrocardiography; Electroencephalography; Guinea Pigs; Histamine H1 Antagonists; Hypnotics and Sedatives; Loratadine; Male; Promethazine; Quinidine; Terfenadine | 1995 |
Vanished behind the counter. Starting this week, you'll need help buying your claritin and nyquil.
Topics: Acetaminophen; Dextromethorphan; Doxylamine; Drug Combinations; Ephedrine; Humans; Legislation, Drug; Loratadine; Methamphetamine; Nasal Decongestants; Promethazine; Pseudoephedrine; United States | 2006 |
Anticholinergic activity of antihistamines.
Topics: Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Motor Neurons; Movement; Promethazine | 2012 |
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions.
Topics: Alprazolam; Databases, Factual; Drug Interactions; Duloxetine Hydrochloride; Electronic Health Records; Humans; Indoles; Loratadine; Muscular Diseases; Promethazine; Simvastatin; Thiophenes | 2012 |